Pharmed Out Director Adrianne Fugh-Berman offered cautions about flibanserin, also known as the "female Viagra." Although the drug's manufacturer, Sprout Pharmaceuticals, cites sexism as the reason the FDA has not approved flibanserin, Dr. Fugh-Berman cites the science: “15 percent of the women in flibanserin trials dropped out because of side effects of sedation and nausea and fatigue," and "it hasn’t been tested long-term.”
She was also quoted in Science 2 as saying, "It's not sexist for the FDA not to approve a drug that it doesn’t believe is effective or safe. It’s a classic marketing technique to first create a problem, and then sell the solution, and that's what’s going on here."
No comments:
Post a Comment